Clinical Trial Update: Fingolimod Versus Dimethyl-fumarate in Multiple Sclerosis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing fingolimod to dimethyl fumarate in relapsing-remitting multiple sclerosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)
• Fingolimod (fingolimod)

Snippet

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 4 | Status: TERMINATED